Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different strategy needed in case of acute coronary syndrome?

27 August 2018 (15:50 - 16:40)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Arnaud Bisson

CHU de Tours, Tours (France)

5 More presentations in this session

Presentation thumbnail

Gastrointestinal bleeding is associated with gastrointestinal cancer in patients with atrial fibrillation treated with anticoagulants - A nationwide study

Doctor P. Rasmussen (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Making sense of real world evidence: addressing the uncertainties surrounding anticoagulation for stroke prevention in non-valvular atrial fibrillation

Doctor A. Banerjee (London, GB)

Abstract Slides

Presentation thumbnail

Risk of mortality depends on the temporal sequence of atrial fibrillation and ischemic stroke

Doctor S. Kim (Seoul, KR)

Abstract Slides

Presentation thumbnail

Temporal occurrence of thromboembolic events with interruption of anticoagulation therapy following left atrial appendage isolation

Doctor S. Mohanty (Austin, US)

Abstract Slides

Presentation thumbnail

High early risk of ischaemic stroke and transient ischaemic attack after diagnosis of non-valvular atrial fibrillation

Doctor C. Martinez (Frankfurt, DE)

Abstract Slides

Access the full session

Session thumbnail

Atrial fibrillation - Stroke prevention

The Event

ESC Congress 2018

27 August 2018 15:50 CET

You may be interested in

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Presentation

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Congress Session

EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources